Abstract
Antimicrobial therapy quickly eradicates susceptible bacilli, but the fight against drug-resistant disease must be waged entirely by host defenses. Knowledge of the two main types of immune response against tuberculosis and of how to manipulate those mechanisms-leading to precisely designed recombinant BCG vaccines-is essential to mounting an effective attack on the current epidemic.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 51-58 |
| Number of pages | 8 |
| Journal | Hospital practice |
| Volume | 28 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1993 |
ASJC Scopus subject areas
- General Medicine